Quantitative Analysis of Prostate MRI: Correlation between Contrast-Enhanced Magnetic Resonance Fingerprinting and Dynamic Contrast-Enhanced MRI Parameters

被引:1
|
作者
Choi, Moon-Hyung [1 ]
Lee, Young-Joon [1 ]
Han, Dongyeob [2 ]
Kim, Dong-Hyun [3 ]
机构
[1] Catholic Univ Korea, Eunpyeong St Marys Hosp, Coll Med, Dept Radiol, Seoul 03312, South Korea
[2] Siemens Healthineers Ltd, Seoul 06620, South Korea
[3] Yonsei Univ, Sch Elect & Elect Engn, Seoul 03722, South Korea
关键词
magnetic resonance fingerprinting; dynamic contrast-enhanced magnetic resonance imaging; quantitative analysis; prostate; prostate neoplasm; MULTIPARAMETRIC MRI; CANCER; DIFFERENTIATION; HYPERPLASIA;
D O I
10.3390/curroncol30120750
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This research aimed to assess the relationship between contrast-enhanced (CE) magnetic resonance fingerprinting (MRF) values and dynamic contrast-enhanced (DCE) MRI parameters including (K-trans, K-ep, V-e, and iAUC). To evaluate the correlation between the MRF-derived values (T1 and T2 values, CE T1 and T2 values, T1 and T2 change) and DCE-MRI parameters and the differences in the parameters between prostate cancer and noncancer lesions in 68 patients, two radiologists independently drew regions-of-interest (ROIs) at the focal prostate lesions. Prostate cancer was identified in 75% (51/68) of patients. The CE T2 value was significantly lower in prostate cancer than in noncancer lesions in the peripheral zone and transition zone. K-trans, K-ep, and iAUC were significantly higher in prostate cancer than noncancer lesions in the peripheral zone (p < 0.05), but not in the transition zone. The CE T1 value was significantly correlated with K-trans, V-e, and iAUC in prostate cancer, and the CE T2 value was correlated to V-e in noncancer. Some CE MRF values are different between prostate cancer and noncancer tissues and correlate with DCE-MRI parameters. Prostate cancer and noncancer tissues may have different characteristics regarding contrast enhancement.
引用
收藏
页码:10299 / 10310
页数:12
相关论文
共 50 条
  • [41] Dynamic contrast-enhanced MRI for preoperative identification of localised prostate cancer
    Villers, Arnauld
    Puech, Philippe
    Leroy, Xavier
    Biserte, Jacques
    Fantoni, Jean-Christophe
    Lemaitre, Laurent
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (08) : 525 - 532
  • [42] Neural network analysis of dynamic contrast-enhanced MRI mammography
    Wismüller, A
    Lange, O
    Dersch, DR
    Hahn, K
    Leinsinger, GL
    ARTIFICIAL NEURAL NETWORKS-ICANN 2001, PROCEEDINGS, 2001, 2130 : 1000 - 1005
  • [43] Quantitative myocardial distribution volume from dynamic contrast-enhanced MRI
    Pack, Nathan A.
    DiBella, Edward V. R.
    Wilson, Brent D.
    McGann, Christopher J.
    MAGNETIC RESONANCE IMAGING, 2008, 26 (04) : 532 - 542
  • [44] Dynamic contrast-enhanced magnetic resonance lymphangiography
    Karen I. Ramirez-Suarez
    Luis O. Tierradentro-Garcia
    Christopher L. Smith
    Ganesh Krishnamurthy
    Fernando A. Escobar
    Hansel J. Otero
    Jordan B. Rapp
    Yoav Dori
    David M. Biko
    Pediatric Radiology, 2022, 52 : 285 - 294
  • [45] Breast Cancer Supplemental Screening: Contrast-Enhanced Mammography or Contrast-Enhanced MRI?
    Rashidi, Ali
    Lowry, Kathryn P.
    Sadigh, Gelareh
    JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2024, 21 (04)
  • [46] Limitations of the keyhole technique for quantitative dynamic contrast-enhanced breast MRI
    Bishop, JE
    Santyr, GE
    Kelcz, F
    Plewes, DB
    JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1997, 7 (04): : 716 - 723
  • [47] Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: Correlation with histopathology
    Cha, S
    Johnson, G
    Wadghiri, YZ
    Jin, O
    Babb, J
    Zagzag, D
    Turnbull, DH
    MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (05) : 848 - 855
  • [48] Feasibility testing of a motion phantom for quantitative Dynamic contrast-enhanced MRI
    Lye, Jessica
    Cahoon, Glenn
    Shelton, Nikki
    Alinaghi-Zadeh, Reza
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S3895 - S3898
  • [49] Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma
    Jackson, A
    Jayson, GC
    Li, KL
    Zhu, XP
    Checkley, DR
    Tessier, JJL
    Waterton, JC
    BRITISH JOURNAL OF RADIOLOGY, 2003, 76 (903): : 153 - 162
  • [50] Evolution from empirical dynamic contrast-enhanced magnetic resonance imaging to pharmacokinetic MRI
    Taylor, JS
    Reddick, WE
    ADVANCED DRUG DELIVERY REVIEWS, 2000, 41 (01) : 91 - 110